Prosecution Insights
Last updated: November 20, 2026

Dxlab Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Dxlab Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Prosecution is currently limited to 1 distinct examiner and 1 distinct art unit. SWITZER, JULIET CAROLINE is the busiest examiner, managing 1 pending office action.

This portfolio shows a narrow prosecution focus, with all active matters residing with 1 examiner. The presence of only 1 pending office action indicates a low volume of current activity at the patent office. For the practitioner, this means that the immediate success of the portfolio depends on the interaction with this 1 examiner. There are no other pending actions to provide a baseline for comparison within the company's current filings. Consequently, the strategy for Dxlab Inc. must be customized to the specific requirements of SWITZER, JULIET CAROLINE. The concentration in 1 distinct art unit further suggests that the company's current patenting efforts are focused on a specific niche within the broader biotechnology field, requiring specialized expertise during the response process. Each communication with the 1 examiner is critical for the development of the company's intellectual property assets.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SWITZER, JULIET CAROLINE 1 42.8% +53.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18260447 METHODS FOR DETECTION OF NUCLEIC ACIDS SWITZER, JULIET CAROLINE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18260447 METHODS FOR DETECTION OF NUCLEIC ACIDS SWITZER, JULIET CAROLINE —

Top Art Units

Art UnitApps
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18260447 METHODS FOR DETECTION OF NUCLEIC ACIDS SWITZER, JULIET CAROLINE 1682 §103§112Other Non-Final OA — Pending Jul 05, 2023

Managing Dxlab Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Dxlab Inc. have?

Dxlab Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Dxlab Inc. applications?

Juliet Caroline Switzer has the most, with 1 of Dxlab Inc.'s pending office actions.

What technology area are Dxlab Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month